U.S. Neurosurgical Holdings, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2019
August 14, 2019 at 05:19 pm EDT
Share
U.S. NeuroSurgical Holdings, Inc. announced earnings results for the second quarter ended June 30, 2019. For the second quarter, the company announced sales was USD 825,000 compared to USD 1.121 million a year ago. Operating income was USD 376,000 compared to USD 355,000 a year ago. Net loss was USD 59,000 compared to net income of USD 77,000 a year ago. For the half year, sales was USD 1.666 million compared to USD 1.986 million a year ago. Operating income was USD 823,000 compared to USD 564,000 a year ago. Net income was USD 127,000 compared to USD 139,000 a year ago. Basic earnings per share from continuing operations was USD 0.02 compared to USD 0.02 a year ago.
U.S. NeuroSurgical Holdings, Inc., through its wholly-owned subsidiaries, holds interests in radiological treatment facilities. The Company owns and operates stereotactic radiosurgery centers, utilizing gamma knife technology. It owns, or holds interests in, the gamma knife and radiation treatment centers, and charges the hospital or medical facility, where the unit is housed and maintained, based on utilization. It is also focused on developing cancer centers featuring radiation therapy. These centers utilize linear accelerators with Intensity Modulated Radiation Therapy and Image Guided Radiation Therapy capabilities. It is focused on launching and development of Medicare advantage plans for seniors by its subsidiaries, Elite Health Plan and Elite Health Plan of Nevada, Inc. Medicare is the federal health insurance program for people ages 65 and over, to cover people under 65 with certain disabilities and people with end-stage renal disease requiring dialysis or kidney transplant.
U.S. NEUROSURGICAL HOLDINGS, INC. 
